GREEN BAY, WI — Andrew Bartkowiak, a Hemophilia Outreach Center patient from Petoskey, became the first Michigan resident with hemophilia B to receive FDA-approved HEMGENIX gene therapy. His treatment offers new hope for fewer bleeds and freedom from regular infusions.
Procedures and Bleeding Disorders: When to Contact Your HTC with Kristin Petrie
Today on Beyond the Bleeds, Heather and John are joined by Kristin Petrie, HOC Nurse Coordinator, to talk about what people with bleeding disorders should know before their next procedure and why contacting your Hemophilia Treatment Center ahead of time is so...

